| Title: |
Daratumumab, lenalidomide, and dexamethasone in systemic light‐chain amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21. |
| Authors: |
Kimmich, Christoph R.; Terzer, Tobias; Benner, Axel; Hansen, Timon; Carpinteiro, Alexander; Dittrich, Tobias; Veelken, Kaya; Jauch, Anna; Huhn, Stefanie; Basset, Marco; Goldschmidt, Hartmut; Müller‐Tidow, Carsten; Schönland, Stefan O.; Hegenbart, Ute |
| Source: |
American Journal of Hematology; Jul2021, Vol. 96 Issue 7, pE253-E257, 5p |
| Database: |
Complementary Index |